IL17A and chronic kidney disease: It reduces IL-6, interleukin-17 (IL-17), IL-12 and other plasma protein levels of inflammation-related cytokines and down-regulated the levels of plasma proteins associated with the NF-kB signaling pathway in CKD patients [259].